Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1N46

CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC

Summary for 1N46
Entry DOI10.2210/pdb1n46/pdb
DescriptorThyroid hormone receptor Beta-1, [4-(4-HYDROXY-3-ISOPROPYL-PHENOXY)-3,5-DIMETHYL-PHENYL]-6-AZAURACIL (3 entities in total)
Functional Keywordstranscription
Biological sourceHomo sapiens (human)
Cellular locationNucleus: P10828
Total number of polymer chains2
Total formula weight59040.34
Authors
Primary citationDow, R.L.,Schneider, S.R.,Paight, E.S.,Hank, R.F.,Chiang, P.,Cornelius, P.,Lee, E.,Newsome, W.P.,Swick, A.G.,Spitzer, J.,Hargrove, D.M.,Patterson, T.A.,Pandit, J.,Chrunyk, B.A.,LeMotte, P.K.,Danley, D.E.,Rosner, M.H.,Ammirati, M.J.,Simons, S.P.,Schulte, G.K.,Tate, B.F.,DaSilva-Jardine, P.
Discovery of a Novel Series of 6-Azauracil-Based Thyroid Hormone Receptor Ligands: Potent, TRbeta Subtype-Selective Thyromimetics
Bioorg.Med.Chem.Lett., 13:379-382, 2003
Cited by
PubMed Abstract: In this communication, we wish to describe the discovery of a novel series of 6-azauracil-based thyromimetics that possess up to 100-fold selectivities for binding and functional activation of the beta(1)-isoform of the thyroid receptor family. Structure-activity relationship studies on the 3,5- and 3'-positions provided compounds with enhanced TR beta affinity and selectivity. Key binding interactions between the 6-azauracil moiety and the receptor have been determined through of X-ray crystallographic analysis.
PubMed: 12565933
DOI: 10.1016/S0960-894X(02)00947-2
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon